The Bicêtre occlusion scale is well suited to assess the efficacy of the Contour embolization device.
J Neuroradiol
; 51(2): 220-223, 2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-37652262
ABSTRACT
BACKGROUND:
The Contour Embolization Device (CED) is typically assessed using coiling angiographic outcomes. However, these scales do not address device-specific problematics. We evaluated the usability of the Bicêtre occlusion scale (BOS) with the CED.RESULTS:
BOS scores can be analyzed as BOSS 0 = no residual flow, BOSS 1 = residual flow inside the CED but with complete neck-sealing, BOSS 2 = neck-remnant, BOSS 3 = aneurysm-remnant, BOSS 1 + 3 = contrast filling inside the device and aneurysmal sac without complete neck-sealing.CONCLUSION:
BOS usage should be encouraged as it provides a more comprehensive assessment of the mechanism of CED occlusion, especially considering the potential prognostic value of the neck sealing assessment.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Aneurisma Intracraneal
/
Embolización Terapéutica
/
Procedimientos Endovasculares
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article